Dr. Turner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
Rm SW331
Boston, MA 02115Phone+1 617-632-6167Fax+1 617-632-4897
Education & Training
- Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1997 - 2000
- Children's National HospitalResidency, Pediatrics, 1994 - 1997
- University of Rochester School of Medicine and DentistryClass of 1994
Certifications & Licensure
- MA State Medical License 2001 - 2026
- NC State Medical License 2020 - 2025
- ME State Medical License 2019 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- 209 citationsPralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.Justin F. Gainor, Giuseppe Curigliano, Dong Wan Kim, Dae Ho Lee, Benjamin Besse
The Lancet. Oncology. 2021-07-01 - 43 citationsA phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.Patrick A. Ott, Anna C. Pavlick, Douglas B. Johnson, Lowell L. Hart, Jeffrey R. Infante
Cancer. 2019-04-01 - 3 citationsGo, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply.Michael Weller, Nicholas Butowski, David Tran, Lawrence Recht, Michael Lim
The Lancet. Oncology. 2017-12-01
Professional Memberships
- Member
- Member
- Fellow
- Member
External Links
- Celldex Therapeuticshttp://www.celldex.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: